Back
JPMorgan Active Value ETF Vs. Olema Pharmaceuticals, Inc. Industry Stock Comparison
Buy
76
JAVA
JPMorgan Active Value ETF
Last Price:
$72.25
Seasonality Move:
3.28%
Buy
66
OLMA
Olema Pharmaceuticals, Inc.
Last Price:
$33.03
Seasonality Move:
-6.94%
Buy
76
JPMorgan Active Value ETF (JAVA)
is a Buy
Is JPMorgan Active Value ETF a Buy, Sell or Hold?
-
The current JPMorgan Active Value ETF [JAVA] share price is $72.25. The Score for JAVA is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
-
JAVA is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
66
Olema Pharmaceuticals, Inc. (OLMA)
is a Buy
Is Olema Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Olema Pharmaceuticals, Inc. [OLMA] share price is $33.05. The Score for OLMA is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
OLMA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
JAVA Stock Price Chart
What is JPMorgan Active Value ETF's stock price today?
-
The JPMorgan Active Value ETF share price today is $72.25Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JAVA is experiencing selling pressure, which indicates risk of future bearish movement.
OLMA Stock Price Chart
What is Olema Pharmaceuticals, Inc.'s stock price today?
-
The Olema Pharmaceuticals, Inc. share price today is $33.05Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and OLMA is experiencing buying pressure, which is a positive indicator for future bullish movement.
JAVA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.78 | Buy |
| Relative Strength Index (14 RSI): | 63.59 | Buy |
| Chaikin Money Flow: | -148141 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (69.19 - 71.67) | Buy |
| Bollinger Bands (100): | (66.86 - 70.26) | Buy |
OLMA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.91 | Buy |
| Relative Strength Index (14 RSI): | 83.22 | Buy |
| Chaikin Money Flow: | 2330353 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.75 - 30.25) | Buy |
| Bollinger Bands (100): | (3.36 - 18.7) | Buy |
JAVA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 71.75 | Buy |
| 20-day SMA: | 70.5 | Buy |
| 50-day SMA: | 69.74 | Buy |
| 200-day SMA: | 65.97 | Buy |
| 8-day EMA: | 71.72 | Buy |
| 20-day EMA: | 70.92 | Buy |
| 50-day EMA: | 68.5 | Buy |
| 200-day EMA: | 42.61 | Buy |
OLMA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29 | Buy |
| 20-day SMA: | 24.82 | Buy |
| 50-day SMA: | 15.4 | Buy |
| 200-day SMA: | 7.73 | Buy |
| 8-day EMA: | 29.46 | Buy |
| 20-day EMA: | 24.88 | Buy |
| 50-day EMA: | 18.05 | Buy |
| 200-day EMA: | 10.4 | Buy |
JPMorgan Active Value ETF Earnings Growth & JAVA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Olema Pharmaceuticals, Inc. Earnings Growth & OLMA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.59 per share, and a decrease next year of $0.42 per share.
JPMorgan Active Value ETF Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Olema Pharmaceuticals, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||